Chen Y, Fachko D, Wu H, Sacha J, Skalsky R
Viruses. 2025; 16(12).
PMID: 39772230
PMC: 11680086.
DOI: 10.3390/v16121923.
Edwards K, Schmidt K, Homad L, Kher G, Xu G, Rodrigues K
Cell Rep Med. 2024; 5(6):101587.
PMID: 38781964
PMC: 11228584.
DOI: 10.1016/j.xcrm.2024.101587.
Torne A, Robertson E
Cancers (Basel). 2024; 16(5).
PMID: 38473352
PMC: 10931536.
DOI: 10.3390/cancers16050991.
Diakite M, Shaw-Saliba K, Lau C
Front Virol. 2023; 3.
PMID: 37476029
PMC: 10358275.
DOI: 10.3389/fviro.2023.1103737.
Afrasiabi A, Ahlenstiel C, Swaminathan S, Parnell G
Clin Transl Immunology. 2023; 12(6):e1454.
PMID: 37337612
PMC: 10276892.
DOI: 10.1002/cti2.1454.
Urgency and necessity of Epstein-Barr virus prophylactic vaccines.
Zhong L, Krummenacher C, Zhang W, Hong J, Feng Q, Chen Y
NPJ Vaccines. 2022; 7(1):159.
PMID: 36494369
PMC: 9734748.
DOI: 10.1038/s41541-022-00587-6.
What do animal models tell us about the role of EBV in the pathogenesis of multiple sclerosis?.
Hassani A, Khan G
Front Immunol. 2022; 13:1036155.
PMID: 36466898
PMC: 9712437.
DOI: 10.3389/fimmu.2022.1036155.
A high-throughput neutralizing assay for antibodies and sera evaluation against Epstein-Barr virus.
Zhong L, Krummenacher C, Zhang W, Hong J, Feng Q, Zhao Q
Virol J. 2022; 19(1):196.
PMID: 36424667
PMC: 9685953.
DOI: 10.1186/s12985-022-01911-1.
Epstein-Barr Virus-Encoded BILF1 Orthologues From Porcine Lymphotropic Herpesviruses Display Common Molecular Functionality.
Mavri M, Kubale V, Depledge D, Zuo J, Huang C, Breuer J
Front Endocrinol (Lausanne). 2022; 13:862940.
PMID: 35721730
PMC: 9204316.
DOI: 10.3389/fendo.2022.862940.
Glycoprotein B Antibodies Completely Neutralize EBV Infection of B Cells.
Hong J, Wei D, Zhong L, Wu Q, Chen K, Zhang W
Front Immunol. 2022; 13:920467.
PMID: 35711430
PMC: 9197244.
DOI: 10.3389/fimmu.2022.920467.
Immunization with a self-assembling nanoparticle vaccine displaying EBV gH/gL protects humanized mice against lethal viral challenge.
Malhi H, Homad L, Wan Y, Poudel B, Fiala B, Borst A
Cell Rep Med. 2022; 3(6):100658.
PMID: 35705092
PMC: 9245003.
DOI: 10.1016/j.xcrm.2022.100658.
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective.
Escalante G, Mutsvunguma L, Muniraju M, Rodriguez E, Ogembo J
Front Immunol. 2022; 13:867918.
PMID: 35493498
PMC: 9047024.
DOI: 10.3389/fimmu.2022.867918.
Multi-site proficiency testing for validation and standardization of assays to detect specific pathogen-free viruses, coronaviruses, and other agents in nonhuman primates.
Yee J, Grant R, Haertel A, Allers C, Carpenter A, Van Rompay K
J Med Primatol. 2022; 51(4):234-245.
PMID: 35426147
PMC: 9851150.
DOI: 10.1111/jmp.12586.
Callitrichine gammaherpesvirus 3 and Human alphaherpesvirus 1 in New World Primate negative for yellow fever virus in Rio de Janeiro, Brazil.
Bonfim F, Monteiro de Mello Mares-Guia M, Horta M, Chame M, De Oliveira Lopes A, Santos R
Mem Inst Oswaldo Cruz. 2022; 117:e210258.
PMID: 35416837
PMC: 9005061.
DOI: 10.1590/0074-02760210258.
Antibody Generation and Immunogenicity Analysis of EBV gp42 N-Terminal Region.
Hong J, Wei D, Wu Q, Zhong L, Chen K, Huang Y
Viruses. 2021; 13(12).
PMID: 34960650
PMC: 8707153.
DOI: 10.3390/v13122380.
Neutralizing antibodies against Epstein-Barr virus infection of B cells can protect from oral viral challenge in the rhesus macaque animal model.
Muhe J, Aye P, Quink C, Eng J, Engelman K, Reimann K
Cell Rep Med. 2021; 2(7):100352.
PMID: 34337567
PMC: 8324488.
DOI: 10.1016/j.xcrm.2021.100352.
Antibody-Mediated Immune Subset Depletion Modulates the Immune Response in a Rabbit () Model of Epstein-Barr Virus Infection.
Osborne A, Atkins H, Balogh K, Brendle S, Shearer D, Hu J
Comp Med. 2020; 70(5):312-322.
PMID: 32972486
PMC: 7574219.
DOI: 10.30802/AALAS-CM-20-000019.
Neutralizing Antibodies Protect against Oral Transmission of Lymphocryptovirus.
Singh S, Homad L, Akins N, Stoffers C, Lackhar S, Malhi H
Cell Rep Med. 2020; 1(3).
PMID: 32724901
PMC: 7386402.
DOI: 10.1016/j.xcrm.2020.100033.
Animal Models for Gammaherpesvirus Infections: Recent Development in the Analysis of Virus-Induced Pathogenesis.
Fujiwara S, Nakamura H
Pathogens. 2020; 9(2).
PMID: 32059472
PMC: 7167833.
DOI: 10.3390/pathogens9020116.
Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders.
Dugan J, Coleman C, Haverkos B
Front Oncol. 2019; 9:127.
PMID: 30931253
PMC: 6428703.
DOI: 10.3389/fonc.2019.00127.